Publications





Selective antitumor activity of ibrutinib in EGFR-mutant non-small cell lung cancer cells.
J Natl Cancer Inst 2014 Sep 10;106(9). Epub 2014 Sep 10.
Department of Thoracic and Cardiovascular Surgery (WG, LW, HL, SW, BD, JAR, WLH, SGS, BF) and Department of Lymphoma and Myeloma (MW, ZO, LZ) and Department of Thoracic/Head and Neck Medical Oncology (JVH, KAD), The University of Texas MD Anderson Cancer Center, Houston, TX; Hamon Center for Therapeutic Oncology, The Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX (JM); Department of Oncology, the First Affiliated Hospital of Nanjing Medical University, Nanjing, China (WG).

IGFBP2/FAK pathway is causally associated with dasatinib resistance in non-small cell lung cancer cells.
Mol Cancer Ther 2013 Dec 15;12(12):2864-73. Epub 2013 Oct 15.
Corresponding Author: Bingliang Fang, Department of Thoracic and Cardiovascular Surgery, Unit 445, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030.

KEAP1-dependent synthetic lethality induced by AKT and TXNRD1 inhibitors in lung cancer.
Cancer Res 2013 Sep 3;73(17):5532-43. Epub 2013 Jul 3.
Departments of Thoracic and Cardiovascular Surgery, Bioinformatics and Computational Biology, and Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

Antitumor activity of a novel STAT3 inhibitor and redox modulator in non-small cell lung cancer cells.
Biochem Pharmacol 2012 May 22;83(10):1456-64. Epub 2012 Feb 22.
Department of Thoracic and Cardiovascular Surgery, the University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

Combination treatment with MEK and AKT inhibitors is more effective than each drug alone in human non-small cell lung cancer in vitro and in vivo.
PLoS One 2010 Nov 29;5(11):e14124. Epub 2010 Nov 29.
Section of Thoracic Molecular Oncology, Department of Thoracic and Cardiovascular Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

FoxM1B regulates NEDD4-1 expression, leading to cellular transformation and full malignant phenotype in immortalized human astrocytes.
Cancer Res 2010 Apr 23;70(7):2951-61. Epub 2010 Mar 23.
Department of Neurosurgery, Unit 1004, The University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA.



OF